Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Tang

Showing results (1331-1340 of 1,415) with videos related to

Pageof 142
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 16, 2024
Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid PeroxidationShan Liu, Jing-Hong Chen, Li-Chao Li, et al.
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Nature Communications|October 12, 2019
Single-molecule level control of host-guest interactions in metallocycle-C<sub>60</sub> complexesJian-Hong Tang, Yueqi Li, Qingqing Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 15, 2020
Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trialsZheng Xiao, Yuan Jiang, Xiao-Fan Chen, et al.
Cell Research|April 29, 2015
In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structuresChao Ni, Yuhui Chen, Musheng Zeng, et al.
World Journal of Clinical Cases|October 17, 2022
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or CJing-Hang Xu, Sa Wang, Da-Zhi Zhang, et al.
ILIVER|July 10, 2025
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosisHuiying Rao, Jia Shang, Qing Xie, et al.
Signal Transduction and Targeted Therapy|June 18, 2023
Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsisSheng-Yuan Zhang, Qiu-Ping Xu, Li-Na Shi, et al.
Antiviral Therapy|October 22, 2020
Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE studyJidong Jia, Jia Shang, Hong Tang, et al.
BMC Cardiovascular Disorders|November 30, 2019
Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart studyLu Fu, Hai Deng, Wei-Dong Lin, et al.
Pageof 142

Showing results (1331-1340 of 1,415) with videos related to

Sort By:
Pageof 142
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 16, 2024
Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid PeroxidationShan Liu, Jing-Hong Chen, Li-Chao Li, et al.
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Nature Communications|October 12, 2019
Single-molecule level control of host-guest interactions in metallocycle-C<sub>60</sub> complexesJian-Hong Tang, Yueqi Li, Qingqing Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 15, 2020
Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trialsZheng Xiao, Yuan Jiang, Xiao-Fan Chen, et al.
Cell Research|April 29, 2015
In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structuresChao Ni, Yuhui Chen, Musheng Zeng, et al.
World Journal of Clinical Cases|October 17, 2022
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or CJing-Hang Xu, Sa Wang, Da-Zhi Zhang, et al.
ILIVER|July 10, 2025
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosisHuiying Rao, Jia Shang, Qing Xie, et al.
Signal Transduction and Targeted Therapy|June 18, 2023
Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsisSheng-Yuan Zhang, Qiu-Ping Xu, Li-Na Shi, et al.
Antiviral Therapy|October 22, 2020
Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE studyJidong Jia, Jia Shang, Hong Tang, et al.
BMC Cardiovascular Disorders|November 30, 2019
Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart studyLu Fu, Hai Deng, Wei-Dong Lin, et al.
Pageof 142